1. Home
  2. YDES vs DGII Comparison

YDES vs DGII Comparison

Compare YDES & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YDES
  • DGII
  • Stock Information
  • Founded
  • YDES 2013
  • DGII 1985
  • Country
  • YDES Taiwan
  • DGII United States
  • Employees
  • YDES N/A
  • DGII N/A
  • Industry
  • YDES
  • DGII Computer peripheral equipment
  • Sector
  • YDES
  • DGII Technology
  • Exchange
  • YDES Nasdaq
  • DGII Nasdaq
  • Market Cap
  • YDES 1.1B
  • DGII 1.3B
  • IPO Year
  • YDES N/A
  • DGII N/A
  • Fundamental
  • Price
  • YDES $18.00
  • DGII $35.71
  • Analyst Decision
  • YDES
  • DGII Buy
  • Analyst Count
  • YDES 0
  • DGII 4
  • Target Price
  • YDES N/A
  • DGII $38.75
  • AVG Volume (30 Days)
  • YDES 103.6K
  • DGII 210.6K
  • Earning Date
  • YDES 09-30-2025
  • DGII 11-12-2025
  • Dividend Yield
  • YDES N/A
  • DGII N/A
  • EPS Growth
  • YDES N/A
  • DGII 147.46
  • EPS
  • YDES N/A
  • DGII 1.14
  • Revenue
  • YDES $510,360.00
  • DGII $420,935,000.00
  • Revenue This Year
  • YDES N/A
  • DGII $2.46
  • Revenue Next Year
  • YDES N/A
  • DGII $7.51
  • P/E Ratio
  • YDES N/A
  • DGII $31.21
  • Revenue Growth
  • YDES 45.76
  • DGII N/A
  • 52 Week Low
  • YDES $5.30
  • DGII $22.39
  • 52 Week High
  • YDES $25.00
  • DGII $38.64
  • Technical
  • Relative Strength Index (RSI)
  • YDES N/A
  • DGII 48.27
  • Support Level
  • YDES N/A
  • DGII $35.82
  • Resistance Level
  • YDES N/A
  • DGII $37.48
  • Average True Range (ATR)
  • YDES 0.00
  • DGII 1.02
  • MACD
  • YDES 0.00
  • DGII -0.20
  • Stochastic Oscillator
  • YDES 0.00
  • DGII 2.40

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.

Share on Social Networks: